PFIZER INC (PFE) - Price, trends, fundamentals and chart - Passport to Wall Street

PFIZER INC (NYSE: PFE)

Overview

current price

$21.91

$21.91

change

0.00 | 0.00%

0.00 | 0.00%

Yesterday's Close

21.91

open

0.00

volume

0.06 M

30d. avg volume.

60.69 M

1 day

0.00 - 0.00

52 weeks

20.92 - 31.54

p/e

15.54

beta

0.6690

market cap

124.26 B

dividend yield

7.85%

Industry

-

News and Commentary

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...

Pfizer CEO Says Company May Shift Overseas Manufacturing To US Amid Looming Tariff Threats: 'Will Th... In light of potential tariff threats from President Donald Trump, Pfizer Inc.'s

Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To... The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong... On Tuesday, Pfizer Inc. (PFE

Market Update: Dow Climbs 100 Points as Tariff Concerns Ease Stocks rose higher Tuesday as market optimism returned on news U.S. has agreed to pause its tariffs on major trading partners Canada and Mexico. The Dow Jones Industrial Average...

Market Update: Stocks Cut Earlier Losses on U.S.-Mexico Tariff Pause, Dow Falls 100 Points Stocks regained some footing Monday, but ultimately fell lower, after the United States and Mexico said tariffs against the southern trading partner would be paused for one month...

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The P... Global health concerns escalated Monday as the U.S. Centers for Disease Control and Prevention reportedly halted collaboration with the World Health Organization, coinciding with...

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on...

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies The U.S. reported its first human death from the H5 bird flu strain this week, causing a spike in vaccine developer stocks Moderna

Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's

StockTwits

StockTwits